The Valley Desk

NCT01464827 · Interventional trial

ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients

Overall registry status Completed

Phase 2

Conditions Chronic Hepatitis C, Hepatitis C (HCV), Hepatitis C Genotype 1

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov